• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分子对接与通用药效团匹配相结合发现多靶点抑制剂。

Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.

作者信息

Wei Dengguo, Jiang Xiaolu, Zhou Lu, Chen Jing, Chen Zheng, He Chong, Yang Kun, Liu Ying, Pei Jianfeng, Lai Luhua

机构信息

Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.

出版信息

J Med Chem. 2008 Dec 25;51(24):7882-8. doi: 10.1021/jm8010096.

DOI:10.1021/jm8010096
PMID:19090779
Abstract

Multitarget drugs have been to be found effective in controlling complex diseases. However, how to design multitarget drugs presents a great challenge. We have developed a computer-assisted strategy to screen for multitarget inhibitors using a combination of molecular docking and common pharmacophore matching. This strategy was successfully applied to screen for dual-target inhibitors against both the human leukotriene A(4) hydrolase (LTA4H-h) and the human nonpancreatic secretory phospholipase A2 (hnps-PLA2). Three compounds screened from the chemical database MDL Available Chemical Directory were found to inhibit these two enzymes at the 10 microM level. Moreover, one synthetic compound matching the common pharmacophores inhibits LTA4H-h and hnps-PLA2 with IC(50) values of 35 nM and 7.3 microM, respectively. The common pharmacophore model can also be used to search small molecule databases or collections of existing inhibitors, as well as to guide combinatorial library design to search for ideal multitarget inhibitors.

摘要

多靶点药物已被证明在控制复杂疾病方面有效。然而,如何设计多靶点药物是一个巨大的挑战。我们开发了一种计算机辅助策略,通过分子对接和共同药效团匹配相结合的方法来筛选多靶点抑制剂。该策略已成功应用于筛选针对人白三烯A(4)水解酶(LTA4H-h)和人非胰腺分泌型磷脂酶A2(hnps-PLA2)的双靶点抑制剂。从化学数据库MDL可获得化学目录中筛选出的三种化合物在10 microM水平上抑制这两种酶。此外,一种符合共同药效团的合成化合物分别以35 nM和7.3 microM的IC(50)值抑制LTA4H-h和hnps-PLA2。共同药效团模型还可用于搜索小分子数据库或现有抑制剂集合,以及指导组合文库设计以寻找理想的多靶点抑制剂。

相似文献

1
Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.通过分子对接与通用药效团匹配相结合发现多靶点抑制剂。
J Med Chem. 2008 Dec 25;51(24):7882-8. doi: 10.1021/jm8010096.
2
Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.基于混合受体结合/MM-GBSA逐残基能量的药效团建模:用于鉴定选择性LTA4H抑制剂作为潜在抗炎药物的增强方法。
Cell Biochem Biophys. 2017 Mar;75(1):35-48. doi: 10.1007/s12013-016-0772-3. Epub 2016 Dec 2.
3
Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.优化 5-羟色胺作为靶向磷脂酶 A2 和白三烯 A4 水解酶的双重功能抑制剂。
Eur J Med Chem. 2013 Jan;59:160-7. doi: 10.1016/j.ejmech.2012.10.057. Epub 2012 Nov 17.
4
Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase.发现环氧化酶和白三烯 A4 水解酶的双重靶标抑制剂。
J Med Chem. 2011 May 26;54(10):3650-60. doi: 10.1021/jm200063s. Epub 2011 May 4.
5
Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking.基于结构的药效团模型和分子对接技术鉴定人白三烯 A4 水解酶抑制剂。
Molecules. 2020 Jun 22;25(12):2871. doi: 10.3390/molecules25122871.
6
Molecular docking and pharmacophore filtering in the discovery of dual-inhibitors for human leukotriene A4 hydrolase and leukotriene C4 synthase.在发现人白三烯 A4 水解酶和白三烯 C4 合酶双重抑制剂的过程中进行分子对接和药效团过滤。
J Chem Inf Model. 2011 Jan 24;51(1):33-44. doi: 10.1021/ci1002813. Epub 2010 Dec 6.
7
High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2).
J Med Chem. 1998 Mar 12;41(6):778-86. doi: 10.1021/jm970579k.
8
Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives.
Bioorg Med Chem Lett. 2008 Dec 15;18(24):6549-52. doi: 10.1016/j.bmcl.2008.10.044. Epub 2008 Oct 14.
9
Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.白三烯A4水解酶/氨肽酶的双重抗炎及选择性抑制机制:基于比较分子动力学和结合自由能分析的见解
J Biomol Struct Dyn. 2016 Nov;34(11):2418-33. doi: 10.1080/07391102.2015.1117991. Epub 2016 Jan 11.
10
Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation.通过多种方式干扰人类花生四烯酸代谢网络来控制炎症。
Acc Chem Res. 2015 Aug 18;48(8):2242-50. doi: 10.1021/acs.accounts.5b00226. Epub 2015 Aug 3.

引用本文的文献

1
Uses of Molecular Docking Simulations in Elucidating Synergistic, Additive, and/or Multi-Target (SAM) Effects of Herbal Medicines.分子对接模拟在阐明草药协同、相加和/或多靶点(SAM)效应中的应用。
Molecules. 2024 Nov 16;29(22):5406. doi: 10.3390/molecules29225406.
2
Computer-Aided Drug Design Boosts RAS Inhibitor Discovery.计算机辅助药物设计助力 RAS 抑制剂的发现。
Molecules. 2022 Sep 5;27(17):5710. doi: 10.3390/molecules27175710.
3
Fine-tuning of a generative neural network for designing multi-target compounds.生成式神经网络的微调用于设计多靶化合物。
J Comput Aided Mol Des. 2022 May;36(5):363-371. doi: 10.1007/s10822-021-00392-8. Epub 2021 May 28.
4
Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking.基于结构的药效团模型和分子对接技术鉴定人白三烯 A4 水解酶抑制剂。
Molecules. 2020 Jun 22;25(12):2871. doi: 10.3390/molecules25122871.
5
LigBuilder V3: A Multi-Target Drug Design Approach.LigBuilder V3:一种多靶点药物设计方法。
Front Chem. 2020 Feb 28;8:142. doi: 10.3389/fchem.2020.00142. eCollection 2020.
6
Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores.基于多重药效团的虚拟筛选概率方法。
Molecules. 2020 Jan 17;25(2):385. doi: 10.3390/molecules25020385.
7
Molecular Docking: Shifting Paradigms in Drug Discovery.分子对接:药物发现中的范式转变。
Int J Mol Sci. 2019 Sep 4;20(18):4331. doi: 10.3390/ijms20184331.
8
Screening drug target combinations in disease-related molecular networks.疾病相关分子网络中的药物靶标组合筛选。
BMC Bioinformatics. 2019 May 1;20(Suppl 7):198. doi: 10.1186/s12859-019-2730-8.
9
Identification of two antiviral inhibitors targeting 3C-like serine/3C-like protease of porcine reproductive and respiratory syndrome virus and porcine epidemic diarrhea virus.鉴定两种针对猪繁殖与呼吸综合征病毒和猪流行性腹泻病毒的 3C 样丝氨酸/3C 样蛋白酶的抗病毒抑制剂。
Vet Microbiol. 2018 Jan;213:114-122. doi: 10.1016/j.vetmic.2017.11.031. Epub 2017 Nov 24.
10
Chinese Herbal Medicine Meets Biological Networks of Complex Diseases: A Computational Perspective.中药与复杂疾病的生物网络:计算视角
Evid Based Complement Alternat Med. 2017;2017:7198645. doi: 10.1155/2017/7198645. Epub 2017 Jun 11.